Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.03.2023 | Case report

Rosuvastatin/ticagrelor interaction

Rhabdomyolysis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gaisenok OV, et al. The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case. [Russian]. Rational Pharmacotherapy in Cardiology 18: 585-590, No. 5, Jan 2022. Available from: URL: https://www.rpcardio.com/jour/article/view/2827/2365 [Russian; summarised from a translation] Gaisenok OV, et al. The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case. [Russian]. Rational Pharmacotherapy in Cardiology 18: 585-590, No. 5, Jan 2022. Available from: URL: https://​www.​rpcardio.​com/​jour/​article/​view/​2827/​2365 [Russian; summarised from a translation]
Metadaten
Titel
Rosuvastatin/ticagrelor interaction
Rhabdomyolysis: case report
Publikationsdatum
01.03.2023
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-35493-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Carbamazepine

Case report

Multiple drugs

Case report

Sintilimab